SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-251143
Filing Date
2023-10-05
Accepted
2023-10-05 09:05:29
Documents
17
Period of Report
2023-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d537538d8k.htm   iXBRL 8-K 66198
2 EX-2.1 d537538dex21.htm EX-2.1 739484
3 EX-10.1 d537538dex101.htm EX-10.1 53053
4 EX-99.1 d537538dex991.htm EX-99.1 45198
8 GRAPHIC g537538g1005123038203.jpg GRAPHIC 3892
9 GRAPHIC g537538g1005123038436.jpg GRAPHIC 3903
  Complete submission text file 0001193125-23-251143.txt   1253569

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ortx-20231005.xsd EX-101.SCH 2517
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20231005_lab.xml EX-101.LAB 17786
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20231005_pre.xml EX-101.PRE 11182
11 EXTRACTED XBRL INSTANCE DOCUMENT d537538d8k_htm.xml XML 3657
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 231309918
SIC: 2836 Biological Products, (No Diagnostic Substances)